{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:11:15Z","timestamp":1792512675961,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1007\/s00415-020-09809-0","type":"journal-article","created":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T07:02:43Z","timestamp":1585724563000},"page":"2735-2748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Expert opinion: use of valproate in girls and women of childbearing potential with epilepsy: recommendations and alternatives based on a review of the literature and clinical experience\u2014a European perspective"],"prefix":"10.1007","volume":"268","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1550-3316","authenticated-orcid":false,"given":"Manuel","family":"Toledo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mostacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Bosak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Jedrzejzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhys H.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Salas-Puig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnaud","family":"Biraben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,1]]},"reference":[{"key":"9809_CR1","unstructured":"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/valproate-related-substances. Accessed 1 Dec 2019"},{"key":"9809_CR2","first-page":"CD003032","volume":"2","author":"F Brigo","year":"2019","unstructured":"Brigo F, Igwe SC, Lattanzi S (2019) Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents. Cochrane Database Syst Rev 2:CD003032","journal-title":"Cochrane Database Syst Rev"},{"key":"9809_CR3","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1016\/S0140-6736(07)60461-9","volume":"369","author":"AG Marson","year":"2007","unstructured":"Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW et al (2007) The SANAD study of effectiveness of valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial. Lancet 369:1016\u20131026","journal-title":"Lancet"},{"key":"9809_CR4","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.seizure.2010.01.014","volume":"19","author":"M Mazurkiewicz-Be\u0142dzi\u0144ska","year":"2010","unstructured":"Mazurkiewicz-Be\u0142dzi\u0144ska M, Szmuda M, Matheisel A (2010) Long-term efficacy of valproate versus lamotrigine in treatment of idiopathic generalized epilepsies in children and adolescents. Seizure 19:195\u2013197","journal-title":"Seizure"},{"key":"9809_CR5","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1212\/01.wnl.0000268699.34614.d3","volume":"69","author":"SF Berkovic","year":"2007","unstructured":"Berkovic SF, Knowlton RC, Leroy RF, Schiemann J, Falter U (2007) Placebo-controlled study of levetiracetam in idiopathic generalized epilepsy. Neurology 69:1751\u20131760","journal-title":"Neurology"},{"key":"9809_CR6","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1212\/WNL.0000000000001930","volume":"85","author":"JA French","year":"2015","unstructured":"French JA, Krauss GL, Wechsler RT, Wang XF, Diventura B, Brandt C et al (2015) Perampanel for tonic-clonic seizures in idiopathic generalized epilepsy. Neurology 85:950\u2013957","journal-title":"Neurology"},{"key":"9809_CR7","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1111\/ane.12216","volume":"129","author":"J Mir\u00f3","year":"2014","unstructured":"Mir\u00f3 J, Aiguabella M, Veciana M, Juvany R, Santurino M, Leiva E et al (2014) Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies. Acta Neurol Scand 129:e20\u2013e23","journal-title":"Acta Neurol Scand"},{"key":"9809_CR8","first-page":"1","volume":"60","author":"A Marson","year":"2019","unstructured":"Marson A (2019) Levetiracetam Inferior to Valproate in Generalized. Unclassif Epilepsy Epilepsia 60:1\u2013248","journal-title":"Unclassif Epilepsy Epilepsia"},{"key":"9809_CR9","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.seizure.2013.09.007","volume":"23","author":"WO Pickrell","year":"2014","unstructured":"Pickrell WO, Lacey AS, Thomas RH, Lyons RA, Smith PEM, Rees MI (2014) Trends in the first antiepileptic drug prescribed for epilepsy between 2000 and 2010. Seizure 23:77\u201380","journal-title":"Seizure"},{"key":"9809_CR10","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1001\/archneur.1981.00510030034003","volume":"38","author":"GWPR Paulson","year":"1981","unstructured":"Paulson GWPR (1981) Teratogenic effects of anticonvulsants. Arch Neurol 38:140\u2013143","journal-title":"Arch Neurol"},{"key":"9809_CR11","doi-asserted-by":"publisher","first-page":"e831","DOI":"10.1212\/WNL.0000000000008001","volume":"93","author":"T Tomson","year":"2019","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E et al (2019) Declining malformation rates with changed antiepileptic drug prescribing. Neurology 93:e831\u2013e840","journal-title":"Neurology"},{"key":"9809_CR12","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1001\/jama.2017.14485","volume":"318","author":"RL Bromley","year":"2017","unstructured":"Bromley RL, Weston J, Marson AG (2017) Maternal use of antiepileptic agents during pregnancy and major congenital malformations in children. JAMA 318:1700\u20131701","journal-title":"JAMA"},{"key":"9809_CR13","doi-asserted-by":"publisher","first-page":"1943","DOI":"10.1212\/WNL.0000000000003157","volume":"87","author":"RL Bromley","year":"2016","unstructured":"Bromley RL, Calderbank R, Cheyne CP, Rooney C, Trayner P, Clayton-Smith J et al (2016) Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology 87:1943\u20131953","journal-title":"Neurology"},{"key":"9809_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.ntt.2018.11.003","volume":"71","author":"RL Bromley","year":"2019","unstructured":"Bromley RL, Baker GA, Clayton-Smith J, Wood AG (2019) Intellectual functioning in clinically confirmed fetal valproate syndrome. Neurotoxicol Teratol 71:16\u201321","journal-title":"Neurotoxicol Teratol"},{"key":"9809_CR15","first-page":"CD010236","volume":"10","author":"R Bromley","year":"2014","unstructured":"Bromley R, Weston J, Adab N, Greenhalgh J, Sanniti A, Mckay AJ et al (2014) Treatment for epilepsy in pregnancy: Neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 10:CD010236","journal-title":"Cochrane Database Syst Rev"},{"key":"9809_CR16","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.yebeh.2018.12.031","volume":"92","author":"MJ Cohen","year":"2019","unstructured":"Cohen MJ, Meador KJ, May R, Loblein H, Conrad T, Baker GA et al (2019) Fetal antiepileptic drug exposure and learning and memory functioning at 6 years of age: The NEAD prospective observational study. Epilepsy Behav 92:154\u2013164","journal-title":"Epilepsy Behav"},{"key":"9809_CR17","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1097\/WCO.0b013e3283292401","volume":"22","author":"RL Bromley","year":"2009","unstructured":"Bromley RL, Baker GA, Meador KJ (2009) Cognitive abilities and behaviour of children exposed to antiepileptic drugs in utero. Curr Opin Neurol 22:162\u2013166","journal-title":"Curr Opin Neurol"},{"key":"9809_CR18","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1001\/jama.2013.2270","volume":"309","author":"J Christensen","year":"2013","unstructured":"Christensen J, Grn\u00f8borg TK, Sr\u00f8ensen MJ, Schendel D, Parner ET, Pedersen LH et al (2013) Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism. JAMA 309:1696\u20131703","journal-title":"JAMA"},{"key":"9809_CR19","doi-asserted-by":"publisher","first-page":"e017248","DOI":"10.1136\/bmjopen-2017-017248","volume":"7","author":"AA Veroniki","year":"2017","unstructured":"Veroniki AA, Rios P, Cogo E, Straus SE, Finkelstein Y, Kealey R et al (2017) Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis. BMJ Open 7:e017248","journal-title":"BMJ Open"},{"key":"9809_CR20","doi-asserted-by":"publisher","first-page":"e72","DOI":"10.1111\/epi.12621","volume":"55","author":"S Edey","year":"2014","unstructured":"Edey S, Moran N, Nashef L (2014) SUDEP and epilepsy-related mortality in pregnancy. Epilepsia 55:e72\u2013e74","journal-title":"Epilepsia"},{"key":"9809_CR21","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.seizure.2009.11.008","volume":"19","author":"G Mawer","year":"2010","unstructured":"Mawer G, Briggs M, Baker GA, Bromley R, Coyle H, Eatock J et al (2010) Pregnancy with epilepsy: obstetric and neonatal outcome of a controlled study. Seizure 19:112\u2013119","journal-title":"Seizure"},{"key":"9809_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","volume":"17","author":"T Tomson","year":"2018","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E et al (2018) Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry. Lancet Neurol 17:530\u2013538","journal-title":"Lancet Neurol"},{"key":"9809_CR23","unstructured":"PRAC recommends new measures to avoid valproate exposure in pregnancy (2018) https:\/\/www.ema.europa.eu\/en\/news\/prac-recommends-new-measures-avoid-valproate-exposure-pregnancy. Accessed 15 Nov 2019"},{"key":"9809_CR24","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/epi.13913","volume":"58","author":"KM Aaberg","year":"2017","unstructured":"Aaberg KM, Sur\u00e9n P, S\u00f8raas CL, Bakken IJ, Lossius MI, Stoltenberg C et al (2017) Seizures, syndromes, and etiologies in childhood epilepsy: the International League Against Epilepsy 1981, 1989, and 2017 classifications used in a population-based cohort. Epilepsia 58:1880\u20131891","journal-title":"Epilepsia"},{"key":"9809_CR25","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1528-1167.2005.00324.x","volume":"46","author":"SR Benbadis","year":"2005","unstructured":"Benbadis SR (2005) Practical management issues for idiopathic generalized epilepsies. Epilepsia 46:125\u2013132","journal-title":"Epilepsia"},{"key":"9809_CR26","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/S1474-4422(18)30495-2","volume":"18","author":"LJ Stephen","year":"2019","unstructured":"Stephen LJ, Harden C, Tomson T, Brodie MJ (2019) Management of epilepsy in women. Lancet Neurol 18:481\u2013491","journal-title":"Lancet Neurol"},{"key":"9809_CR27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1111\/epi.12305","volume":"54","author":"E Beghi","year":"2013","unstructured":"Beghi E, Giussani G, Grosso S, Iudice A, La NA, Pisani F et al (2013) Withdrawal of antiepileptic drugs: guidelines of the Italian League Against Epilepsy. Epilepsia 54:2\u201312","journal-title":"Epilepsia"},{"key":"9809_CR28","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.jogc.2016.06.008","volume":"38","author":"RD Wilson","year":"2016","unstructured":"Wilson RD, De Bie I, Armour CM, Brown RN, Campagnolo C, Carroll JC et al (2016) Joint SOGC-CCMG opinion for reproductive genetic carrier screening: an update for all Canadian providers of maternity and reproductive healthcare in the era of direct-to-consumer testing. J Obstet Gynaecol Canada 38:742\u2013762","journal-title":"J Obstet Gynaecol Canada"},{"key":"9809_CR29","unstructured":"Epilepsies: diagnosis and management (2019) https:\/\/www.nice.org.uk\/guidance\/cg137. https:\/\/www.nice.org.uk\/guidance\/cg137. Accessed 1 Dec 2019"},{"key":"9809_CR30","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S1474-4422(17)30114-X","volume":"16","author":"HJ Lamberink","year":"2017","unstructured":"Lamberink HJ, Otte WM, Geerts AT, Pavlovic M, Ramos-Lizana J, Marson AG et al (2017) Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol 16:523\u2013531","journal-title":"Lancet Neurol"},{"key":"9809_CR31","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1111\/epi.13437","volume":"57","author":"T Tomson","year":"2016","unstructured":"Tomson T, Battino D, Bonizzoni E, Craig J, Lindhout D, Perucca E et al (2016) Withdrawal of valproic acid treatment during pregnancy and seizure outcome: observations from EURAP. Epilepsia 57:173\u2013177","journal-title":"Epilepsia"},{"key":"9809_CR32","doi-asserted-by":"publisher","first-page":"279","DOI":"10.5698\/1535-7597-13.6.279","volume":"13","author":"M Koubeissi","year":"2013","unstructured":"Koubeissi M (2013) Levetiracetam: more evidence of safety in pregnancy. Epilepsy Curr 13:279\u2013281","journal-title":"Epilepsy Curr"},{"key":"9809_CR33","first-page":"279","volume":"13","author":"KJ Meador","year":"2014","unstructured":"Meador KJ, Baker GA, Browning N, Cohen MJ, Bromley RL, Clayton-Smith J et al (2014) Breastfeeding in children of women taking antiepileptic drugs: Cognitive outcomes at age 6 years. JAMA Pediatr 13:279\u2013281","journal-title":"JAMA Pediatr"},{"key":"9809_CR34","first-page":"67","volume-title":"Understanding genetics: a district of columbia guide for patients and health professionals, vol 1","author":"G Alliance","year":"2010","unstructured":"Alliance G (2010) Understanding genetics: a district of columbia guide for patients and health professionals, vol 1. Genetic Alliance, Washington, DC, pp 67\u201372"},{"key":"9809_CR35","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.ejpn.2011.05.007","volume":"15","author":"S Auvin","year":"2011","unstructured":"Auvin S, Chhun S, Berquin P, Ponchel E, Delano\u00eb C, Chiron C (2011) Aggravation of absence seizure related to levetiracetam. Eur J Paediatr Neurol 15:508\u2013511","journal-title":"Eur J Paediatr Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-020-09809-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-020-09809-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T19:38:54Z","timestamp":1626723534000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-020-09809-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,1]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["9809"],"URL":"https:\/\/doi.org\/10.1007\/s00415-020-09809-0","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,1]]},"assertion":[{"value":"4 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All the authors declare that they received advisory honoraria from Sanofi to work in this consensus. No other potential conflict of interest is declared.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}]}}